Akero Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 6.28 M | $298.24 M | -6.80% | 7.69% |
| GENERAL ATLANTIC, L.P. | 11/13/2025 | 5.73 M | $272.25 M | 0.00% | 7.02% |
| BLACKROCK, INC. | 11/12/2025 | 5.70 M | $270.76 M | -1.33% | 6.98% |
| RTW INVESTMENTS, LP | 11/14/2025 | 5.48 M | $260.07 M | 0.00% | 6.70% |
| VANGUARD GROUP INC | 11/07/2025 | 4.53 M | $214.94 M | -0.06% | 5.54% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 4.25 M | $201.88 M | 24.69% | 5.20% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 4.00 M | $189.97 M | 31.50% | 4.90% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 3.96 M | $187.81 M | 13.02% | 4.84% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 3.81 M | $180.89 M | -15.51% | 4.66% |
| STATE STREET CORP | 11/14/2025 | 3.41 M | $162.11 M | 24.36% | 4.18% |
| BELLEVUE GROUP AG | 11/14/2025 | 2.39 M | $113.44 M | 20.35% | 2.92% |
| ALKEON CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.85 M | $87.88 M | 0.00% | 2.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.79 M | $84.79 M | 3.67% | 2.19% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 1.69 M | $80.22 M | 9.99% | 2.07% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.66 M | $78.98 M | -38.64% | 2.04% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.30 M | $61.60 M | -1.74% | 1.59% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.22 M | $57.79 M | -14.18% | 1.49% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 1.20 M | $56.98 M | 0.00% | 1.47% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.14 M | $53.93 M | 24.01% | 1.39% |
| FMR LLC | 11/13/2025 | 1.08 M | $51.26 M | 15.85% | 1.32% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 1.06 M | $50.27 M | 100.00% | 1.30% |
| HOLOCENE ADVISORS, LP | 11/14/2025 | 1.06 M | $50.10 M | -1.90% | 1.29% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 926.44 K | $44.00 M | -6.10% | 1.13% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 855.77 K | $40.63 M | 11.76% | 1.05% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 810.57 K | $38.49 M | 41.29% | 0.99% |
| REDMILE GROUP, LLC | 11/14/2025 | 747.82 K | $35.51 M | -3.42% | 0.92% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/14/2025 | 720.00 K | $34.19 M | 0.00% | 0.88% |
| CITADEL ADVISORS LLC | 11/14/2025 | 685.84 K | $32.56 M | -41.37% | 0.84% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 663.44 K | $31.50 M | 100.00% | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 643.64 K | $30.56 M | -9.83% | 0.79% |
| WOODLINE PARTNERS LP | 11/14/2025 | 639.60 K | $30.37 M | -74.08% | 0.78% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 626.53 K | $29.75 M | -2.19% | 0.77% |
| NORTHERN TRUST CORP | 11/14/2025 | 626.02 K | $29.72 M | -1.31% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 612.13 K | $29.06 M | -0.35% | 0.75% |
| LOOMIS SAYLES & CO L P | 11/13/2025 | 527.18 K | $25.03 M | -2.52% | 0.65% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 526.20 K | $24.98 M | 149.03% | 0.64% |
| ABRDN PLC | 11/07/2025 | 502.91 K | $23.88 M | 28.43% | 0.62% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 500.00 K | $23.74 M | 0.00% | 0.61% |
| BARCLAYS PLC | 11/12/2025 | 487.23 K | $23.13 M | -8.66% | 0.60% |
| WEISS ASSET MANAGEMENT LP | 11/14/2025 | 486.00 K | $23.08 M | 1,603.71% | 0.59% |
| BRAIDWELL LP | 11/14/2025 | 475.40 K | $22.57 M | 100.00% | 0.58% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 473.63 K | $22.49 M | -13.70% | 0.58% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 435.29 K | $20.67 M | 117.65% | 0.53% |
| VIVO CAPITAL, LLC | 11/14/2025 | 434.69 K | $20.64 M | 0.00% | 0.53% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 418.98 K | $19.89 M | 22.51% | 0.51% |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 409.54 K | $19.44 M | -1.89% | 0.50% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 397.01 K | $18.85 M | 246.57% | 0.49% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 378.86 K | $17.99 M | -2.90% | 0.46% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 11/14/2025 | 377.15 K | $17.91 M | 2.77% | 0.46% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 366.78 K | $17.41 M | 0.00% | 0.45% |
Akero Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 324 institutional investors and hedge funds held shares of Akero Therapeutics, Inc.. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 6.28 M
GENERAL ATLANTIC, L.P.: 5.73 M
BlackRock, Inc.: 5.7 M
RTW INVESTMENTS, LP: 5.48 M
VANGUARD GROUP INC: 4.53 M
WELLINGTON MANAGEMENT GROUP LLP: 4.25 M
111.90% of Akero Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 106.39 M shares in the last 24 months. This purchase volume represents approximately $4.90 B in transactions.